No Added Benefit From Revascularization in Low-Risk CAS
Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization.
Medscape Medical News
source https://www.medscape.com/viewarticle/992524?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992524?src=rss
Comments
Post a Comment